Tag: pharmaceutical patents

Discover why drug patents rarely last 20 years on the market. Learn about the Hatch-Waxman Act, patent cliffs, and how regulatory exclusivity shapes pharmaceutical pricing and generic access.

When pharmaceutical patents expire, drug prices plummet-often by 80% or more. Generic competition transforms markets, saving patients and systems billions. Here’s how it works, why it’s delayed, and what’s changing in 2026.

Landmark court decisions in generic patent law determine when affordable drugs reach the market. From Amgen v. Sanofi to Amarin v. Hikma, these rulings shape drug prices, patent strategies, and patient access.